Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Depression Confirmed as Osteoporosis Risk Factor

By LabMedica International staff writers
Posted on 22 Nov 2009
A recently published review article summarized studies relating clinical depression and osteoporosis and concluded that a clear connection exists between the two.

Osteoporosis is the most widespread degenerative disease in the developed world, afflicting about 33% of women and 20% of men in the over 50 age group. More...
In an endeavor to better understand risk factors for the syndrome, investigators at the Hebrew University of Jerusalem (Israel) reviewed research articles that related loss of bone mass, which characterizes osteoporosis, to evidence of clinical depression.

Their findings, based on the evaluation of 23 research projects conducted in eight countries that compared bone density among 2,327 people suffering from depression against 21,141 nondepressed individuals were published in the September 2009 issue of the journal Biological Psychiatry. The results showed that overall, depressed individuals displayed lower bone mass density than nondepressed subjects. The association between depression and bone mass density was similar in the spine, hip, and forearm. It was stronger in women than in men, and in premenopausal than postmenopausal women. Only women individually diagnosed for major depression by a psychiatrist displayed significantly lower bone mass density; women diagnosed by self-rating questionnaires did not. Depressed subjects had increased urinary levels of bone breakdown markers as compared to their nondepressed counterparts.

Based on these findings the authors concluded that, "All individuals psychiatrically diagnosed with major depression are at risk for developing osteoporosis, with depressed young women showing the highest risk. These patients should be periodically evaluated for progression of bone loss and signs of osteoporosis, allowing the use of antiosteoporotic prophylactic and therapeutic treatments."

Related Links:
Hebrew University of Jerusalem




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.